Work

86Y-DOTA0-d-Phe1-Tyr3-octreotide (SMT487)—a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

Year: 2003

Type: article

Study design: Clinical Trial

Source: European Journal of Nuclear Medicine and Molecular Imaging

DOI: 10.1007/s00259-003-1117-1

Authors: François Jamar, Raffaella Barone, Isabelle Mathieu, Stéphan Walrand, Daniel Labar, Pascal Carlier, Joëlle Camps, Horst Schran, TianLing Chen, M. Charles Smith, Hakim Bouterfa, Roelf Valkema, Eric P. Krenning, Larry K. Kvols, Stanislas Pauwels

Institutions: UCLouvain, KU Leuven, Novartis (United States), Erasmus MC, University of South Florida, Moffitt Cancer Center

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2020347413

FWCI: 10.33

Cites: 31

Cited by: 242

Related to: 9